Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
公司代码INSP
公司名称Inspire Medical Systems Inc
上市日期May 03, 2018
CEOHerbert (Timothy P)
员工数量1246
证券类型Ordinary Share
年结日May 03
公司地址5500 Wayzata Blvd Ste 1600
城市GOLDEN VALLEY
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编55416-1237
电话17639575037
网址https://www.inspiresleep.com/
公司代码INSP
上市日期May 03, 2018
CEOHerbert (Timothy P)